Legal Representation
Attorney
John R. Schaefer
USPTO Deadlines
Next Renewal Deadline
777 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-08-24)
Due Date
August 24, 2027
Grace Period Ends
February 24, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
41 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 14, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Nov 8, 2024 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Mar 7, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Mar 7, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Mar 7, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Mar 7, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Mar 7, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Mar 7, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Feb 27, 2022 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Feb 3, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Feb 3, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Nov 24, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Aug 24, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jul 30, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jul 30, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Jul 30, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jun 11, 2021 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Jun 8, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jun 8, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 19, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| May 5, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| May 5, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| May 5, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| May 5, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| May 5, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 28, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Mar 28, 2021 | GNFR | O | FINAL REFUSAL E-MAILED |
| Mar 28, 2021 | CNFR | R | FINAL REFUSAL WRITTEN |
| Mar 2, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 22, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jan 22, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jan 22, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Oct 19, 2020 | RFNT | P | REFUSAL PROCESSED BY IB |
| Oct 1, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sep 30, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Sep 15, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Sep 14, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sep 13, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Sep 11, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 11, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 10, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 001
Chemicals and biological preparations for use in science and industry; nucleic acids for other than medical and veterinary purposes; nucleic recombinant acids, synthetic deoxyribonucleic acids for other than medical and veterinary purposes; chemical and biological reagents for non-medical purposes, namely, reagents for use in scientific apparatus for chemical or biological analysis; chemical and biological reagents for scientific and research purposes; human or animal stem cells and parts thereof for non-medical purposes; cultures of microorganisms for non-medical and non-veterinary purposes; human or animal cells and parts thereof for scientific and research purposes; cultures of microorganisms for scientific and research purposes, other than for medical or veterinary use
Class 005
Chemical and biological reagents for medical and veterinary purposes; diagnostic and test reagents for medical and veterinary use; human or animal cells and parts thereof for medical and veterinary purposes; cultures of microorganisms for medical and veterinary purposes
Class 042
Design services relating to the creation and alteration of chemical and biological reagents, namely, custom design and development of chemical reagents and biochemical assays; custom design and development of chemical reagents and biochemical assays, namely, design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses, namely, scientific development of recombinant viruses; design services relating to the creation and alteration of antibodies, namely, scientific development of antibodies; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof, namely, scientific development of cell lines, elementary cells and structural parts thereof
Classification
International Classes
001
005
042